NASDAQ: BLUEBluebird Bio Inc Stock Ownership - Who owns Bluebird Bio?
Insider buying vs selling
Have Bluebird Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Richard A. Colvin | Chief Medical Officer | 2025-03-03 | 584 | $3.92 | $2.29kSell |
| Thomas J. Klima | Chief Commercial Operating Officer | 2025-03-03 | 500 | $3.92 | $1.96kSell |
| Andrew Obenshain | President and CEO | 2025-03-03 | 921 | $3.92 | $3.61kSell |
| Joseph Vittiglio | Chief Business Legal Officer | 2025-02-03 | 238 | $7.39 | $1.76kSell |
| Richard A. Colvin | Chief Medical Officer | 2025-02-03 | 64 | $7.39 | $473.15Sell |
| Thomas J. Klima | Chief Commercial Operating Officer | 2025-02-03 | 122 | $7.39 | $901.95Sell |
| Andrew Obenshain | President and CEO | 2025-02-03 | 86 | $7.39 | $635.80Sell |
| Andrew Obenshain | President and CEO | 2025-01-06 | 140 | $9.24 | $1.29kSell |
| Richard A. Colvin | Chief Medical Officer | 2025-01-06 | 19 | $9.24 | $175.56Sell |
| Andrew Obenshain | President and CEO | 2024-12-10 | 971 | $0.42 | $404.91Sell |
BLUE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BLUE insiders and whales buy or sell their stock.
BLUE Shareholders
What type of owners hold Bluebird Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Steven Gillis | 32.76% | 3,207,607 | $13.28M | Insider |
| Tvm V Life Science Ventures Gmbh Co Kg | 23.03% | 2,254,357 | $9.33M | Insider |
| Axel Polack | 23.03% | 2,254,357 | $9.33M | Insider |
| Arch Venture Fund VII LP | 18.32% | 1,793,588 | $7.43M | Insider |
| Geertjan Mulder | 11.80% | 1,155,121 | $4.78M | Insider |
| Blackrock Inc | 7.24% | 708,669 | $2.93M | Institution |
| Vanguard Group Inc | 5.37% | 525,414 | $2.18M | Institution |
| Nick Leschly | 4.95% | 484,538 | $2.01M | Insider |
| Geode Capital Management LLC | 2.39% | 233,514 | $966.75k | Institution |
| State Street Corp | 2.02% | 197,921 | $819.39k | Institution |
BLUE vs Biotech Stocks
Bluebird Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.